Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Volpara Health to raise A$18 mln to fund US, Asian expansion

Volpara Health to raise A$18 mln to fund US, Asian expansion

By Rebecca Howard

April 30 (BusinessDesk) - ASX-listed Volpara Health Technologies is raising A$18 million through a placement to institutional investors and a share purchase plan to speed up growth in the US and fund the rollout of direct sales into Asia.

Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, is raising A$15 million selling shares in a placement at 60 Australian cents apiece to institutional investors, a 13 percent discount to the last trading price before the shares were halted. It plans to raise another A$3 million from existing shareholders, who will be able to buy up to A$15,000 of shares at the same price.

The health-tech company's cash on hand will rise to A$21.8 million from A$4.6 million once the capital raising is completed, and comes after Volpara's operational cash outflow narrowed to NZ$7.7 million in the year ended March 31 from NZ$8.2 million a year earlier.

Volpara's earmarked some NZ$9 million to expand its US direct sales, marketing and customers teams to accelerate sales growth with a view to delivering 9 percent market share by the end of the 2019 financial year. An additional NZ$4 million will develop new features in an effort to boost the firm's fee per woman, while NZ$2 million will begin the rollout of direct sales into Asia, a rapidly growing market. That will leave the company with NZ$3 million of working capital.

The placement is expected to settle on May 4 while the share purchase plan will run from May 7 to May 25. The allotment will take place May 31.

Morgans Corporate and Bell Potter Securities have been appointed the joint lead managers.

Volpara said it's achieved regulatory clearances for Japan, Taiwan, Australia and South Korea. Part of the capital raise will be used to target private hospital chains, find the right distribution partners and ensure Volpara is in government-run trials as necessary, it said.

Separately the company said its cash position was NZ$4.8 million in the final quarter of the year to March and its receipts from customers reached NZ$3.07 million in the 12-month period, the first time they have surpassed NZ$3 million. It holds no debt.

"This has been our best sales quarter to date. We aimed high, setting ambitious milestones for the year, which we've met both in terms of ARR (annualised recurring revenue) and US market penetration, now at NZ$3.6 million and 3.2 percent respectively," said Volpara chief executive Ralph Highnam.

(BusinessDesk)

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Stats NZ: Unemployment Declines As Underutilisation Rises

The seasonally adjusted unemployment rate decreased to 4.7 percent in the March 2021 quarter, continuing to fall from its recent peak of 5.2 percent in the September 2020 quarter but remaining high compared with recent years, Stats NZ said today. ... More>>

ALSO:

Digitl: The Story Behind Vodafone’s FibreX Court Ruling

Vodafone’s FibreX service was in the news this week. What is the story behind the Fair Trading Act court case? More>>

Commerce Commission: Vodafone Found Guilty Of Misleading Conduct Over 'FibreX' Service

Vodafone NZ Limited has been found guilty of engaging in conduct that was liable to mislead consumers in relation to its FibreX branded broadband service. In a case brought by the Commerce Commission and heard last year, the Auckland District Court ... More>>


Westpac: Announces Strong Financial Result

Westpac New Zealand (Westpac NZ) [i] says a strong half-year financial result has been driven by better than expected economic conditions. Chief Executive David McLean said while the global COVID-19 pandemic was far from over, the financial effect on ... More>>

MYOB: SME Confidence In Economic Performance Still Cautious

New insights from the annual MYOB Business Monitor have shown the SME sector is still cautious about the potential for further economic recovery, with two-in-five (41%) expecting the New Zealand economy to decline this year. The latest research ... More>>

Tourism Industry Aotearoa: Trans-Tasman Bubble Benefits NZ

More people have entered New Zealand than have left since the opening of the trans-Tasman bubble, says Tourism Industry Aotearoa. Since the first flight from Australia to New Zealand took off from Sydney to Auckland on 19 April, the two-way Tasman travel ... More>>